Skip to main content

Animations

MJFF Publications

4181 - 4190 of 8761 Results
Title
Year
  • Year
  • 2020
  • 2015
  • 2025
  • 2019
  • 2025
  • 2020
  • 2020
  • 2018
  • 2019
  • 2023
  • Summary Details
    OPEN
    Title: The Michael J. Fox Foundation’s Strategies for Accelerating Translation of LRRK2 into Therapies for Parkinson Disease
    Journal Name: Cells
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/cells9081878
    Citation Count: 6
  • Summary Details
    RESTRICTED
    Title: Cell penetrating peptide-mediated transport enables the regulated secretion of accumulated cargoes from mast cells
    Journal Name: Journal of Controlled Release
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.jconrel.2015.02.005
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Sex differences in the diagnosis latency of Parkinson's disease in Latin America
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107344
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Proximity extension assay testing reveals novel diagnostic biomarkers of atypical parkinsonian syndromes
    Journal Name: Journal of Neurology, Neurosurgery & Psychiatry
    Publisher: BMJ
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1136/jnnp-2018-320151
    Citation Count: 50
  • Summary Details
    OPEN
    Title: Novel regulators of heparan sulfate proteoglycans modulate cellular uptake of α-synuclein fibrils
    Journal Name: Communications Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s42003-025-08786-2
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Patient-centred management of Parkinson's disease – Authors' reply
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30360-4
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Enhanced Susceptibility of PINK1 Knockout Rats to α-Synuclein Fibrils
    Journal Name: Neuroscience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuroscience.2020.04.032
    Citation Count: 19
  • Summary Details
    OPEN
    Title: TOX3 Variants Are Involved in Restless Legs Syndrome and Parkinson’s Disease with Opposite Effects
    Journal Name: Journal of Molecular Neuroscience
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s12031-018-1031-4
    Citation Count: 12
  • Summary Details
    OPEN
    Title: No genetic evidence for involvement of alcohol dehydrogenase genes in risk for Parkinson's disease
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2019.11.006
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Generation of gene-corrected isogenic controls from Parkinson's disease patient iPSC lines carrying the pathogenic SNCA p.A53T variant
    Journal Name: Stem Cell Research
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.scr.2023.103125
    Citation Count: 1
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.